2021-2022 Session
Change SessionH.225 (Act 46)
An act relating to possession of a therapeutic dosage of buprenorphine
- Sponsor(s)
- Last Recorded Action
- Senate 5/21/2021 - House message: Governor approved bill on June 1, 2021
Bill/Resolution Text
- Other Text
-
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to possession of a therapeutic dosage of buprenorphine
Detailed Status
Regular Session 2021-2022
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to possession of a therapeutic dosage of buprenorphine
Roll Call History
Regular Session 2021-2022
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to possession of a therapeutic dosage of buprenorphine
Committee Meetings
Regular Session 2021-2022
| Meeting Date | Committee |
|---|
An act relating to possession of a therapeutic dosage of buprenorphine
Meeting Full List
Regular Session 2021-2022
Thursday, February 11, 2021
- Committee(s):
- House Committee on Human Services
- 15 mins after Floor
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Walk-through
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Thursday, April 1, 2021
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Sarah George, State's Attorney, Chittenden County
Willa Farrell, Director, Court Diversion and Pre-Trial Services
Friday, April 2, 2021
- Committee(s):
- House Committee on Human Services
- -
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
review of latest draft
- 1:15 PM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Kimberly Blake, Physician, Burlington
Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
Tuesday, April 6, 2021
- Committee(s):
- House Committee on Human Services
- After the Floor adjourns
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Mark-up and vote
Wednesday, April 7, 2021
- Committee(s):
- House Committee on Judiciary
- 11:10 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Rep. Ann Pugh, Sponsor
Tuesday, April 13, 2021
- Committee(s):
- House Committee on Human Services
- 3:20 PM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Updates
Thursday, April 29, 2021
- Committee(s):
- Senate Committee on Health and Welfare
- 8:30 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Joint meeting with the Senate Committee on Judiciary
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Meeting livestreamed here.
Sarah George, State's Attorney, Chittenden County
David Scherr, Assistant Attorney General, Vermont Attorney General's Office
Dennis Wygmans, State's Attorney, Addison County State’s Attorney’s Office
Erica Marthage, State's Attorney, Bennington County
Michael E. Schirling, Commissioner, Department of Public Safety
- 10:30 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Joint meeting with the Senate Committee on Judiciary
Brenda Siegel, Self-Advocate, Newfane
Meeting livestreamed here.
Mark Levine, Commissioner, Vermont Department of Health
Brady Heward, Child and Adolescent Psyciatrist, UVM Medical Center
Jess Kirby, Syringe Exchange Employee, Howard Center Safe Recovery
Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
Thursday, April 29, 2021
- Committee(s):
- Senate Committee on Judiciary
- 8:30 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Joint Hearing with Senate Committee on Health and Welfare
Sarah George, State's Attorney, Chittenden County
Michele Childs, Legislative Counsel, Office of Legislative Counsel
David Scherr, Assistant Attorney General, Vermont Attorney General's Office
Dennis Wygmans, State's Attorney, Addison County State’s Attorney’s Office
Erica Marthage, State's Attorney, Bennington County
Michael E. Schirling, Commissioner, Department of Public Safety
- 10:20 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Joint meeting with the Senate Committee on Health and Welfare
Brenda Siegel, Self-Advocate, Newfane
Mark Levine, Commissioner, Vermont Department of Health
Brady Heward, Child and Adolescent Psyciatrist, UVM Medical Center
Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
Jess Kirby, Syringe Exchange Employee, Howard Center Safe Recovery
Friday, April 30, 2021
- Committee(s):
- Senate Committee on Judiciary
- 8:45 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Committee Discussion
Wednesday, May 5, 2021
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Committee discussion
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Friday, May 7, 2021
- Committee(s):
- Senate Committee on Judiciary
- 8:30 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Mark- up and Vote
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Wednesday, May 12, 2021
- Committee(s):
- House Committee on Human Services
- 11:15 AM
-
H.225 - An act relating to possession of a therapeutic dosage of buprenorphine
Review Senate Amendment
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Committee Documents
An act relating to possession of a therapeutic dosage of buprenorphine
Witnesses Who Testified
Regular Session 2021-2022
House Committee on Human Services
- Kimberly Blake, Physician, Burlington
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Willa Farrell, Director, Court Diversion and Pre-Trial Services
- Sarah George, State's Attorney, Chittenden County
- Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
House Committee on Judiciary
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Rep. Ann Pugh, Sponsor
Senate Committee on Health and Welfare
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Sarah George, State's Attorney, Chittenden County
- Brady Heward, Child and Adolescent Psyciatrist, UVM Medical Center
- Jess Kirby, Syringe Exchange Employee, Howard Center Safe Recovery
- Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
- Mark Levine, Commissioner, Vermont Department of Health
- Erica Marthage, State's Attorney, Bennington County
- David Scherr, Assistant Attorney General, Vermont Attorney General's Office
- Michael E. Schirling, Commissioner, Department of Public Safety
- Brenda Siegel, Self-Advocate, Newfane
- Dennis Wygmans, State's Attorney, Addison County State’s Attorney’s Office
Senate Committee on Judiciary
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Sarah George, State's Attorney, Chittenden County
- Brady Heward, Child and Adolescent Psyciatrist, UVM Medical Center
- Jess Kirby, Syringe Exchange Employee, Howard Center Safe Recovery
- Julea Larson, Supervisor of Recovery Support Services, Turning Point Center, Bennington
- Mark Levine, Commissioner, Vermont Department of Health
- Erica Marthage, State's Attorney, Bennington County
- David Scherr, Assistant Attorney General, Vermont Attorney General's Office
- Michael E. Schirling, Commissioner, Department of Public Safety
- Brenda Siegel, Self-Advocate, Newfane
- Dennis Wygmans, State's Attorney, Addison County State’s Attorney’s Office
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.225 in the Regular Session 2021-2022.
No committee of conference members found for H.225 in the Regular Session 2021-2022.
An act relating to possession of a therapeutic dosage of buprenorphine
Committee of Conference Meetings
Regular Session 2021-2022
| Meeting Date | Committee |
|---|
An act relating to possession of a therapeutic dosage of buprenorphine
Committee of Conference Meeting Full List
Regular Session 2021-2022
No committee of conference meeting history found for H.225 in the Regular Session 2021-2022.
No committee of conference report found for H.225 in the Regular Session 2021-2022.
Act
An act relating to possession of a therapeutic dosage of buprenorphine
Statutes Affected
Regular Session 2021-2022
| Statute |
|---|
| 18 V.S.A. § 4234. Depressant, stimulant, and narcotic drugs |
